Bachem Holding AG - Company Profile

Powered by

All the sales intelligence you need on Bachem Holding AG in one solution.

$395 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Bachem Holding AG fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Bachem Holding AG.

Back to companies

Bachem Holding AG: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

The following section provides information on Bachem Holding AG’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Bachem Holding AG's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Kuno Sommer

Chairman Executive Board Since: 2012 Age: 70

Mr. Kuno Sommer has been the Chairman of the company since 2012. Prior to this, he served as the Chief Executive Officer of Berna Biotech from 2000 to 2006. Previously, he served in various executive positions at Roche from 1986 to 1999. Previously, Mr. Sommer served as the Chairman of the board of Sunstar-Holding AG, Kenta Biotech AG, and TargImmune Therapeutics AG. He served as a member of the Board of Directors of Spexis AG.

Read Hide full bio of Kuno Sommer

Anne-Kathrin Stoller

Chief Commercial Officer; Chief Executive Officer Senior Management Since: 2026

Ms. Anne-Kathrin Stoller has been the Chief Executive Officer and Chief Commercial Officer of the company since January 2026. Previously, she served as Chief Marketing Officer and Head of Business Development and Sales for Europe of the company. Ms Stoller served as Chief Operating Officer for the Americas region and President of Bachem Americas.

Read Hide full bio of Anne-Kathrin Stoller

Alain Schaffter

Chief Financial Officer Senior Management Since: 2020 Age: 49

Mr. Alain Schaffter has been the Chief Financial Officer of Bachem since 2020. Prior to this, he worked as a consultant for several companies in the Life Science Industry, supporting them in specific projects like Reporting, IFRS conversion or IPO preparation and was appointed as the Head of Special Finance Projects of Solvias AG in August 2018. Mr. Schaffter also served as the Head of Group Finance of Acino Group and Chief Financial Officer of Polyphor in 2016.

Read Hide full bio of Alain Schaffter

Hans Van Hees

Chief Operating Officer Senior Management Since: 2025 Age: 57

Mr. Hans Van Hees has been the Chief Operating Officer of the company since September 2025. Previously, he was the company's Chief Operating Officer for Europe. Prior to this, he served as Chief Technology Officer of Pharma Resource Group. He also held various positions at Johnson & Johnson.

Read Hide full bio of Hans Van Hees

Gunther Loidl

Chief Technology Officer Senior Management Since: 2015 Age: 56

Mr. Gunther Loidl has been the Chief Technology Officer of Bachem since 2015. Prior to this, he held various functions in Active Pharmaceutical Ingredient Manufacturing and Research and Development of the company. Mr. Loidl served as the Vice President of Research and Development of the company in 2012.

Read Hide full bio of Gunther Loidl
Gain a 360-degree view of Bachem Holding AG and make more informed decisions for your business Gain a 360-degree view of Bachem Holding AG and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer